Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder

Clinical trial NCT01844115 · COMPLETED

Trial details

NCT number: NCT01844115
Sponsor: Forest Laboratories
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2013-04-30
Primary completion: 2014-03-31
Enrollment: 415

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.